Why Has Japan Been Slow to Vaccinate? Exploring Vaccine Hesitancy and Rollout Challenges
Japan’s slow COVID-19 vaccination results from vaccine hesitancy, limited government funding, and a thorough regulatory process. Domestic clinical trials for Pfizer-BioNTech delayed approvals. Furthermore, an aging population has created a shortage of healthcare workers, impacting vaccination rates. The rollout of vaccines in Japan has faced logistical challenges. The initial supply was limited, causing delays in … Read more